帕金增强了HeLa宫癌细胞中的Gefitinib诱导的Anoikis
Byung Chul Jung1,2, Sung-Hun Woo2, Sung Hoon Kim3,4
1Department of Nutritional Sciences and Toxicology, University of California, Berkeley, CA, U.S.A.
Anticancer research
|April 27, 2024
概括
帕金表达增强了gefitinib的作用.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生化学
背景情况:
- 格菲提尼布在子宫癌中显示出抗癌作用,通过 anoikis.
- 帕金蛋白在抗癌药物疗效中的作用已知,但其对宫癌中gefitinib的影响尚不清楚.
研究的目的:
- 调查帕金过度表达是否增强了gefitinib对HeLa宫癌细胞的治疗作用.
- 探索帕金斯对gefitinib诱导的瘤的影响机制.
主要方法:
- 通过trypan蓝色试验和流式细胞计量评估HeLa细胞活力和亡.
- 使用显微镜观察到的细胞脱离,粘附和扩散.
- 粘附分子的变化通过共聚焦显微镜和西方涂料分析.
主要成果:
- 帕金表达增强了gefitinib诱导的细胞脱离,通过改变actin细胞骨架组织.
- 帕金减少了脱离细胞的重新连接和相互作用.
- 低剂量gefitinib与帕金匹配高剂量gefitinib的疗效.
结论:
- 帕金表达促进gefitinib诱导的阿诺基斯,增强其对宫癌的疗效.
- 帕金可以作为一种策略,以提高gefitinib在宫癌治疗中的抗癌活性.
更多相关视频
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
18.7K
09:38Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
Published on: August 11, 2017
8.8K
相关概念视频
The Intrinsic Apoptotic Pathway
6.5K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
